Healthcare provider profile · identity verified

Robert D Robinson, M.D.

Internal Medicine · BARRE, VT · NPI 1366507154

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	411	102
Amlodipine Besylate	Amlodipine Besylate	397	99
Omeprazole	Omeprazole	306	83
Eliquis	Apixaban	283	49
Metoprolol Succinate	Metoprolol Succinate	272	67
Lisinopril	Lisinopril	269	75
Rosuvastatin Calcium	Rosuvastatin Calcium	258	57
Levothyroxine Sodium	Levothyroxine Sodium	251	60
Gabapentin	Gabapentin	246	46
Tamsulosin Hcl	Tamsulosin Hcl	244	47
Hydrochlorothiazide	Hydrochlorothiazide	229	60
Atorvastatin Calcium	Atorvastatin Calcium	213	59
Furosemide	Furosemide	186	45
Albuterol Sulfate Hfa	Albuterol Sulfate	165	52
Potassium Chloride	Potassium Chloride	163	18
Finasteride	Finasteride	158	27
Pravastatin Sodium	Pravastatin Sodium	149	39
Simvastatin	Simvastatin	131	33
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	124	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	116	16
Ozempic	Semaglutide	116	14
Fluoxetine Hcl	Fluoxetine Hcl	114	32
Clopidogrel	Clopidogrel Bisulfate	111	13
Montelukast Sodium	Montelukast Sodium	102	26
Prednisone	Prednisone	98	37
Lorazepam	Lorazepam	97	26
Hydromorphone Hcl	Hydromorphone Hcl	95	14
Trazodone Hcl	Trazodone Hcl	93	24
Pantoprazole Sodium	Pantoprazole Sodium	88	27
Famotidine	Famotidine	86	16
Glipizide Er	Glipizide	83	23
Metformin Hcl Er	Metformin Hcl	81	21
Metformin Hcl	Metformin Hcl	76	21
Baclofen	Baclofen	73	suppressed
Allopurinol	Allopurinol	72	20
Sertraline Hcl	Sertraline Hcl	71	24
Levetiracetam	Levetiracetam	70	suppressed
Meloxicam	Meloxicam	69	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	67	17
Oxybutynin Chloride Er	Oxybutynin Chloride	66	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	65	12
Fluticasone Propionate	Fluticasone Propionate	64	20
Citalopram Hbr	Citalopram Hydrobromide	61	16
Quetiapine Fumarate	Quetiapine Fumarate	59	suppressed
Oxycodone Hcl	Oxycodone Hcl	57	12
Amitriptyline Hcl	Amitriptyline Hcl	54	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	54	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	suppressed
Ranolazine Er	Ranolazine	52	suppressed
Mirtazapine	Mirtazapine	50	15
Paroxetine Hcl	Paroxetine Hcl	50	suppressed
Warfarin Sodium	Warfarin Sodium	50	12
Clonazepam	Clonazepam	49	suppressed
Carvedilol	Carvedilol	48	12
Celecoxib	Celecoxib	46	12
Spironolactone	Spironolactone	46	13
Amoxicillin	Amoxicillin	45	24
Torsemide	Torsemide	45	suppressed
Jardiance	Empagliflozin	44	12
Diltiazem 24hr Er	Diltiazem Hcl	43	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	43	suppressed
Irbesartan	Irbesartan	41	12
Duloxetine Hcl	Duloxetine Hcl	40	suppressed
Methocarbamol	Methocarbamol	40	11
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Bupropion Xl	Bupropion Hcl	38	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	27
Ventolin Hfa	Albuterol Sulfate	36	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Tramadol Hcl	Tramadol Hcl	33	suppressed
Xarelto	Rivaroxaban	33	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	31	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	suppressed
Nadolol	Nadolol	31	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	21
Valacyclovir	Valacyclovir Hcl	31	suppressed
Atenolol	Atenolol	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	22
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Ibuprofen	Ibuprofen	29	13
Nitroglycerin	Nitroglycerin	29	18
Alprazolam	Alprazolam	28	suppressed
Methadone Hcl	Methadone Hcl	27	suppressed
Naproxen	Naproxen	27	suppressed
Cephalexin	Cephalexin	26	21
Pregabalin	Pregabalin	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Fluconazole	Fluconazole	25	11
Ketoconazole	Ketoconazole	25	13
Lovastatin	Lovastatin	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	18
Trulicity	Dulaglutide	23	suppressed
Verapamil Er	Verapamil Hcl	23	suppressed
Valsartan	Valsartan	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Synthroid	Levothyroxine Sodium	21	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	19	suppressed
Glipizide	Glipizide	19	suppressed
Humulin R	Insulin Regular, Human	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Nystatin	Nystatin	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	18	suppressed
Creon	Lipase/Protease/Amylase	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Liothyronine Sodium	Liothyronine Sodium	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Invokana	Canagliflozin	16	suppressed
Methimazole	Methimazole	16	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Fentanyl	Fentanyl	15	suppressed
Methylphenidate Er	Methylphenidate Hcl	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Colchicine	Colchicine	14	suppressed
Dapagliflozin	Dapagliflozin Propanediol	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Deblitane	Norethindrone	13	suppressed
Dexmethylphenidate Hcl Er	Dexmethylphenidate Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Famotidine	Famotidine/Pf	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Metolazone	Metolazone	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Dexmethylphenidate Hcl	Dexmethylphenidate Hcl	12	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Penicillin V Potassium	Penicillin V Potassium	12	12
Ibu	Ibuprofen	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error